Home Home Home Inbox Home Search

Event

Efficacy and Safety of Tralokinumab in Two Phase III Trials of Severe, Uncontrolled Asthma [Board No. 422]

Location: Board no. 422
Session Type: RAPiD: Rapid Abstract Poster Discussion Session
Sunday
May
20
2:15 PM
4:15 PM

Speaker(s)/Author(s)

AnnaMaria Péterffy

MD
AstraZeneca

Christopher E. Brightling

BSc(Hons), MBBS, PhD
University of Leicester;University of Leicester, Maurice Shock Medical School

Gene Colice

MD
AstraZeneca

Edward Piper

MBBS
AstraZeneca

Ulf Sjobring

MD, PhD
AstraZeneca

Karin Bowen

PhD
AstraZeneca

Peter Wessman

PhD
AstraZeneca

Reynold Panettieri

PhD
Rutgers University;The State University of New Jersey

View Abstract

Efficacy and Safety of Tralokinumab in Two Phase III Trials of Severe, Uncontrolled Asthma

Parent Sessions

  • A101 - MECHANISMS AND CLINICAL FEATURES OF SEVERE ASTHMA...
    05-20-2018 2:15 PM - 4:15 PM
    • Home Home Home Inbox Home Search